Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 3 call positions ($47.9m notional), 4 put positions ($321.7m notional) – listed below, not included above.
Holdings, Q1 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $156.6m14.71% | Added +133.8k |
| GSK PLC GSK | $133.9m12.58% | Added +241.0k |
| HORIZON THERAPEUTICS PUB L HZNP | $89.4m8.40% | Reduced -245.3k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $54.8m5.15% | Added +1.5m |
| UNITED THERAPEUTICS CORP DEL UTHR | $49.7m4.67% | Reduced -10.7k |
| SYNDAX PHARMACEUTICALS INC SNDX | $46.7m4.38% | Added +588.3k |
| COMMUNITY HEALTH SYS INC NEW CYH | $44.5m4.18% | Added +7.1m |
| BIOGEN INC BIIB | $42.8m4.02% | Added +16.4k |
| ILLUMINA INC ILMN | $39.7m3.73% | Added +30.5k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $37.7m3.54% | Added +3.6m |
| CATALENT INC CTLT | $37.7m3.54% | Reduced -118.1k |
| DANAHER CORPORATION DHR | $37.5m3.52% | Reduced -13.9k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $24.8m2.33% | Added +130.9k |
| CENTENE CORP DEL CNC | $18.2m1.71% | Added +73.9k |
| ICON PLC ICLR | $16.4m1.54% | Added +10.1k |
| AVANTOR INC AVTR | $15.2m1.42% | Added +117.4k |
| SERES THERAPEUTICS INC COM | $14.4m1.35% | Added +335.7k |
| BIO-TECHNE CORP TECH | $14.0m1.31% | Added +172.0k |
| VERA THERAPEUTICS INC VERA | $13.9m1.30% | Added +1.4m |
| INTRA-CELLULAR THERAPIES INC ITCI | $11.8m1.11% | New |
| EHEALTH INC EHTH | $11.6m1.09% | New |
| GUARDANT HEALTH INC GH | $11.3m1.06% | Added +337.0k |
| VAXCYTE INC PCVX | $11.2m1.05% | Added +120.6k |
| HUMANA INC HUM | $11.1m1.04% | Added +1.9k |
| IONIS PHARMACEUTICALS INC IONS | $10.8m1.02% | Added +62.4k |
| SHOCKWAVE MED INC SWAV | $10.3m0.97% | New |
| TENET HEALTHCARE CORP THC | $8.4m0.79% | Reduced -112.7k |
| MODEL N INC MODN | $8.1m0.76% | Added +24.0k |
| HCA HEALTHCARE INC HCA | $7.4m0.69% | New |
| XENON PHARMACEUTICALS INC XENE | $7.3m0.68% | Reduced -72.4k |
| AMNEAL PHARMACEUTICALS INC AMRX | $7.2m0.68% | Added +4.4m |
| PENNANT GROUP INC PNTG | $6.0m0.57% | New |
| PUMA BIOTECHNOLOGY INC PBYI | $6.0m0.56% | Added +430.4k |
| TARO PHARMACEUTICAL INDS LTD TARO | $6.0m0.56% | Added +19.8k |
| ZAI LAB LTD ZLAB | $5.7m0.54% | New |
| LIQUIDIA CORPORATION LQDA | $5.0m0.47% | Reduced -566.5k |
| IQVIA HLDGS INC IQV | $2.9m0.27% | Added +3.5k |
| HESKA CORP HSKA | $2.6m0.24% | Added +6.9k |
| BIOHAVEN LTD BHVN | $2.5m0.24% | Unchanged |
| MERUS N V MRUS | $2.4m0.22% | Reduced -55.5k |
| MEDPACE HLDGS INC MEDP | $2.2m0.21% | New |
| GOHEALTH INC CL A NEW | $2.0m0.19% | Added +74.5k |
| XOMA ROYALTY CORPORATION XOMA | $1.9m0.18% | Added +3.1k |
| EVOLUS INC EOLS | $1.9m0.18% | Reduced -492.2k |
| AGILENT TECHNOLOGIES INC A | $1.8m0.17% | Added +1.2k |
| GOSSAMER BIO INC GOSS | $1.7m0.16% | Added +1.2m |
| REVVITY INC RVTY | $1.6m0.15% | Added +1.2k |
| PARATEK PHARMACEUTICALS INC PRTK | $1.6m0.15% | New |
| ARGENX SE ARGX | $1.4m0.13% | Added +360 |
| AFFIMED N V COM | $1.4m0.13% | Added +1.6m |
| AEROVATE THERAPEUTICS INC COM | $1.0m0.10% | Reduced -41.0k |
| REPLIGEN CORP RGEN | $952.2k0.09% | Reduced -51.3k |
| AADI BIOSCIENCE INC WHWK | $737.9k0.07% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $608.1k0.06% | New |
| AC IMMUNE SA ACIU | $291.5k0.03% | Unchanged |
Sold out since Q4 2022
| Security | Value then |
|---|---|
| SANOFI SNY | $77.7m1.6m shares |
| ENVISTA HOLDINGS CORPORATION NVST | $21.6m642.4k shares |
| SPDR SER TR XBI | $17.9m216.1k shares |
| HALEON PLC HLN | $15.1m1.9m shares |
| APELLIS PHARMACEUTICALS INC APLS | $8.0m154.8k shares |
| IVERIC BIO INC OPHT | $7.5m350.7k shares |
| INCYTE CORP INCY | $5.1m64.0k shares |
| PLIANT THERAPEUTICS INC PLRX | $2.7m137.4k shares |
| CABALETTA BIO INC CABA | $2.6m282.9k shares |
| FATE THERAPEUTICS INC FATE | $439.5k43.6k shares |
| GLYCOMIMETICS INC | $304.8k100.6k shares |
| ELEDON PHARMACEUTICALS INC ELDN | $154.5k67.7k shares |
| SONIDA SENIOR LIVING INC SNDA | $147.4k11.8k shares |
| BOLT BIOTHERAPEUTICS INC | $40.5k31.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $167.8m410.0k shares | New |
| INVESCO QQQ TR QQQ · Put | $144.4m450.0k shares | New |
| AMARIN CORP PLC Call | $21.9m14.6m shares | Added |
| AMEDISYS INC AMED · Call | $16.5m224.3k shares | New |
| ELEVANCE HEALTH INC ELV · Call | $9.5m20.6k shares | Reduced |
| SPDR SER TR XBI · Put | $6.1m80.0k shares | New |
| AMN HEALTHCARE SVCS INC AMN · Put | $3.3m40.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |